First Trust Nasdaq PharmaceuFTXHETF
13F holders, Q2 2024 (June 30)24holders +5
4new positions
0sold out
1famous investor
$27.25avg. 13F price*
At the end of Q2 2024, 24 institutions reported holding First Trust Nasdaq Pharmaceu (FTXH) in their 13F filings, up 5 from Q1 2024. 4 opened new positions and 0 sold out. The largest holders were Goldman Sachs Group Inc. ($1.8M), LPL Financial LLC ($1.4M) and Royal Bank of Canada ($685K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- First Trust Nasdaq Pharmaceu
- CUSIP
- 33738R837
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $949K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 85,987 shares bought and 78,794 shares sold, net +7,193 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Goldman Sachs Group Inc. | 0.00% | Add +49.2% | 66,497 | $1.8M |
| LPL Financial LLC | 0.00% | Reduce -13.8% | 53,115 | $1.4M |
| Royal Bank of Canada | 0.00% | Add +494.7% | 25,133 | $685K |
| Susquehanna International Group, LLP | 0.00% | Add +34.4% | 24,078 | $656K |
| Old Mission Capital LLC | 0.01% | New | 19,459 | $530K |
| Janney Montgomery Scott LLC | 0.00% | Reduce -51.6% | 17,783 | $484K |
| Steward Partners Investment Advisory, LLC | 0.01% | Reduce -72.2% | 17,762 | $484K |
| WMG Financial Advisors, LLC | 0.19% | Reduce -13.9% | 13,386 | $365K |
| Citadel Advisors | 0.00% | New | 12,698 | $346K |
| Ameritas Investment Partners, Inc. | 0.01% | Add +7.5% | 12,040 | $328K |
| Stratos Wealth Partners, LTD. | 0.00% | Reduce -8.9% | 8,361 | $228K |
| Debussy Capital Management LP | 0.06% | Reduce -5.8% | 8,047 | $219K |
| Lanark Financial, Inc. | 0.02% | Reduce -1.1% | 6,147 | $167K |
| Bank of Montreal | 0.00% | Reduce -18.1% | 4,888 | $136K |
| International Assets Investment Management, LLC | 0.01% | New | 2,662 | $73K |
| Osaic Holdings, Inc. | 0.00% | Reduce -24.4% | 1,775 | $48K |
| Wells Fargo & Company | 0.00% | Add +0.0% | 1,297 | $35K |
| Harbour Investments, Inc. | 0.00% | No change | 836 | $23K |
| Continuum Advisory, LLC | 0.00% | No change | 650 | $18K |
| Asset Dedication, LLC | 0.00% | No change | 593 | $16K |
| Capital Investment Advisory Services, LLC | 0.00% | No change | 450 | $12K |
| IFP Advisors, Inc | 0.00% | No change | 307 | $8K |
| UBS Group AG | 0.00% | New | 29 | $790 |
| Morgan Stanley | 0.00% | No change | 2 | $56 |
"% of holder's portfolio" is FTXH's weight in each manager's 13F, not the share of First Trust Nasdaq Pharmaceu the manager owns.